The targeting vector contains an FRT-flanked splice acceptor/IRES/lacZ/puromycin fusion gene followed by a loxP site inserted upstream of exon 3 and a second loxP site followed by an F3-flanked neomycin cassette inserted downstream of exon 6. (J:266163)